We aimed to investigate the extent of alterations in pro/antioxidant balance blood patients with relapsing–remitting multiple sclerosis (RRMS) relation drug-modified therapy, gender, disability score, and disease duration. 161 (67 men 94 women, aged 24–69 years, median 43.0) 29 healthy individuals (9 20 25–68 41.0) were included study. measured activity superoxide dismutase (SOD), glutathione p...

In the last decade, a new armamentarium of immune-based therapies have been developed and tested in patients with multiple sclerosis. Some of these therapies are showing a high level of efficacy, with an acceptable adverse effect profile. Because present therapies have significant limitations in slowing disease progression, require injections, are sometimes associated with significant side effe...